AI shortens drug discovery to around 1 year in China, Insilico CEO says

Insilico Medicine has reduced drug discovery timelines to 9-13 months by combining generative AI with China-based research operations, compared to 4.5 years using traditional methods. The company's strategy leverages China's lower costs, streamlined regulation, and automated lab infrastructure to compete on speed against Western pharma giants while maintaining partnerships with Eli Lilly, Takeda, and others.

This Wire brief sits within Fusion42's coverage of Digital Health, and 3 sources have reported it between 20 Jul 2026 and 23 Jul 2026.